BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

XHEvsPBEETF Comparison

ETF 1

XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of

US Health Care

-0.76%

Full XHE fund page

VS

ETF 2

PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of

BioTech & Genomics

-1.96%

Full PBE fund page

State Street SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. XHE's top 2 sector exposures are Healthcare and Finance. In contrast, PBE's top sector exposures are Healthcare. XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.59% for PBE. XHE is up 1.67% year-to-date (YTD) with +$13M in YTD flows. PBE performs better with 14.59% YTD performance, and +$114M in YTD flows. Run a side-by-side ETF comparison of XHE and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

XHE vs PBE performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 09/10/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	XHE PBE	-4.95%-0.70%	+9.88%+12.83%	+1.67%+14.59%	+11.16%+35.63%	+7.03%+57.51%	-31.12%+23.66%
Flows	XHE PBE	+$5M+$44M	+$14M+$117M	+$13M+$114M	+$2M+$113M	-$264M+$62M	-$380M+$64M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	XHE PBE	+24.14%+19.58%	+22.78%+19.33%	+22.23%+20.48%	+24.84%+22.57%
Max drawdown	XHE PBE	-7.53%-5.73%	-18.20%-11.70%	-24.35%-22.21%	-49.37%-33.32%
Max drawdown duration	XHE PBE	22d7d	207d166d	565d324d	1772d1509d

Trading data

Create an account to view trading data

Join for free

	XHE	PBE
Last sale 9/11/2026 at 1:30 PM	$90.01	$92.91
Previous close 09/10/2026	$89.53	$93.03
Consolidated volume 09/10/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	XHE	PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/11/2026 at 1:30 PM

Live

Closed

	XHE	PBE
Last price	$90.01	$92.91
1D performance	+0.54%	-0.13%
AuM	$170.24 M	$405.87 M
E/R	0.35%	0.59%

Characteristics

	XHE	PBE
Management strategy	Passive	Passive
Provider	State Street Investment Management	Invesco
Benchmark	S&P Health Care Equipment Select Industry Index	Dynamic Biotech & Genome Intellidex Index
N° of holdings	66	30
Asset class	Equities	Equities
Trailing 12m distribution yield	Join	Join
Inception date	January 26, 2011	June 23, 2005
ESG	No	No

More XHE data on Trackinsight

More PBE data on Trackinsight

Exposure

Countries

XHE

USA

93.56%

Other

6.44%

PBE

USA

97.13%

Other

2.87%

Sectors

XHE

Healthcare

98.72%

Other

1.28%

PBE

Healthcare

100%

Other

0%

Diversification

XHE

Total weight of top 15 holdings out of 15

30.19%

PBE

Total weight of top 15 holdings out of 15

61.32%

Top 15 holdings

Data as of July 31, 2026

XHE

AtriCure, Inc.

2.14%

Glaukos Corp.

2.13%

Dentsply Sirona, Inc.

2.08%

Enovis Corp.

2.07%

Integer Holdings Corp.

2.07%

Butterfly Network, Inc.

2.06%

Neogen Corp.

2.05%

Artivion, Inc.

2.05%

Baxter International, Inc.

2.01%

CONMED Corp.

1.99%

Merit Medical Systems, Inc.

1.98%

QuidelOrtho Corp.

1.94%

ICU Medical, Inc.

1.88%

Tandem Diabetes Care, Inc.

1.88%

Inspire Medical Systems, Inc.

1.85%

PBE

Amgen, Inc.

5.16%

Vertex Pharmaceuticals, Inc.

4.96%

Royalty Pharma Plc

4.91%

Regeneron Pharmaceuticals, Inc.

4.90%

Biogen, Inc.

4.85%

Gilead Sciences, Inc.

4.44%

Alnylam Pharmaceuticals, Inc.

4.34%

United Therapeutics Corp.

4.06%

CareDx, Inc.

4.01%

Bio-Techne Corp.

3.66%

Illumina, Inc.

3.27%

Vericel Corp.

3.25%

Protagonist Therapeutics, Inc.

3.24%

Incyte Corp.

3.19%

Veracyte, Inc.

3.07%

Frequently asked questions about XHE and PBE

How have the XHE and PBE ETFs performed in 2026?

As of September 10, 2026, XHE is up 1.67% year-to-date (YTD), while PBE has returned 14.59%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or PBE?

Year-to-date, the XHE ETF saw +$13M in flows, compared to +$114M for PBE.

Which ETF is more volatile: XHE or PBE?

Over the past year, XHE had a volatility of 22.78%, while PBE experienced 19.33%.

Which ETF is bigger: XHE or PBE?

As of September 10, 2026, XHE holds $170.24 M in assets under management (AUM), while PBE manages $405.87 M.

What sectors do the XHE and PBE ETFs invest in?

XHE leans toward sectors like Healthcare. Meanwhile, PBE focuses on Healthcare.

What are the top holdings of the XHE ETF and PBE ETF?

XHE top holdings include AtriCure, Inc., Glaukos Corp. and Dentsply Sirona, Inc.. PBE holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc.

XHEvsPBEETF Comparison

State Street SPDR S&P Health Care Equipment ETF

Invesco Dynamic Biotechnology & Genome ETF

XHE vs PBE performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the XHE and PBE ETFs performed in 2026?

As of September 10, 2026, XHE is up 1.67% year-to-date (YTD), while PBE has returned 14.59%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or PBE?

Year-to-date, the XHE ETF saw +$13M in flows, compared to +$114M for PBE.

Which ETF is more volatile: XHE or PBE?

Over the past year, XHE had a volatility of 22.78%, while PBE experienced 19.33%.

Which ETF is bigger: XHE or PBE?

As of September 10, 2026, XHE holds $170.24 M in assets under management (AUM), while PBE manages $405.87 M.

What sectors do the XHE and PBE ETFs invest in?

XHE leans toward sectors like Healthcare. Meanwhile, PBE focuses on Healthcare.

What are the top holdings of the XHE ETF and PBE ETF?

XHE top holdings include AtriCure, Inc., Glaukos Corp. and Dentsply Sirona, Inc.. PBE holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc.

Which ETF is more diversified: XHE or PBE?

XHE holds 66 securities with 30.19% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.32%.

Expert-Built ETF Portfolios, All in One Place